| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.045 | 0.8 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |